AAAna Ayala-Lugo

Ana Ayala-Lugo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Ayala-Lugo has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mutaciones en los genes NPM1, IDH1 e IDH2 en pacientes paraguayos con leucemia mieloide aguda

    by Lady Franco-Benegas, Maria Paz Mujica, Valerie Jolly, Victor Salinas, Jose Zarza, Diana Gonzalez, Denisse Di Tore, Laura Morel, Juan Jose Bogado, Monica Labrano, et al.

    Introducción: La leucemia mieloide aguda (LMA) surge a partir de la expansión clonal de blastos mieloides en sangre periférica, médula ósea u otros tejidos. Su etiología se encuentra asociada al desarrollo de mutaciones genéticas. La identificación de mutaciones potencialmente accionables es de relevancia clínica en el diagnóstico, pronóstico y tratamiento de la LMA. Objetivo: Identificar y describir el perfil de mutaciones en los genes NPM1, IDH1 e IDH2 en pacientes paraguayos con diagnóstico de LMA. Metodología: Se realizó un estudio retrospectivo epidemiológico molecular en 32 muestras de pacientes con LMA portadores de mutaciones en el gen NPM1. La detección de variantes genéticas se llevó a cabo mediante PCR en tiempo real y secuenciación Sanger. Resultados: La mutación de NPM1 más frecuentemente detectada fue la de tipo A, identificada en el 94% (30/32) de los casos. Además, se encontraron mutaciones en IDH1 e IDH2 en el 40% (13/32) de los casos, siendo la variante IDH2 R140Q la más predominante. La co-ocurrencia más frecuente se observó entre mutaciones en NPM1 e IDH2. Conclusión: Este estudio proporciona información relevante sobre el perfil de mutaciones en NPM1, IDH1 e IDH2 en la LMA en Paraguay, resaltando la importancia de estos marcadores tanto en la estratificación en grupo de riesgo como en el potencial beneficio de terapias dirigidas.

  • Open Access

    Asociación de polimorfismos del gen del receptor de vitamina D y la gravedad de la psoriasis

    by Claudia Romina Contreras, Isabel Acosta Colman, Ana Ayala Lugo, Valerie Jolly, María Teresa Martínez de Filártiga, Maria Eugenia Acosta

    Varios estudios han investigado la relación de la Vitamina D con enfermedades inmunomediadas y más recientemente, los polimorfismos de su receptor han sido relacionados con la susceptibilidad a padecer psoriasis y otras enfermedades inmunomediadas. Este estudio investigó la relación entre los polimorfismos del vitamin D receptor (VDR) y la gravedad de la psoriasis en 50 pacientes con psoriasis y 50 controles sanos en la Cátedra de Dermatología de la FCM_UNA durante mayo a noviembre del 2018. Se analizaron 3 polimorfismos del VDR (ApaI, TaqI y FokI) y se midieron los niveles de vitamina D. Aunque no se encontró asociación entre los polimorfismos y la gravedad de la psoriasis, sí se halló una asociación alélica en el polimorfismo TaqI en los pacientes con psoriasis. Se identificaron asociaciones significativas entre la insuficiencia de vitamina D y los polimorfismos TaqI y ApaI. También se encontró una relación entre estos mismos polimorfismos y pacientes con psoriasis que presentaban síndrome metabólico. Los niveles bajos de vitamina D fueron más comunes en pacientes con psoriasis moderada a severa y en aquellos con síndrome metabólico. Este fue el primer estudio de asociación genética realizado en Paraguay para la psoriasis, permitiendo la inclusión de los primeros 50 pacientes al biobanco de enfermedades inmunomediadas del país.

  • Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

    by Luísa Corrêa de Araújo Koury, Haesook T. Kim, Maria Soledad Undurraga, Juan Ramon Navarro-Cabrera, Victor Salinas, Pablo Muxi, Raul A. M. Melo, Ana Beatriz F Gloria, Katia B.B. Pagnano, Elenaide C. Nunes, et al.

    The introduction of all-trans retinoic acid combined with anthracyclines has significantly improved the outcomes for patients diagnosed with acute promyelocytic leukemia (APL), and this strategy remains the standard of care in countries in which arsenic trioxide is not affordable. However, data from national registries and real-world databases indicate that low- and middle-income countries (LMIC) still face disappointing results, mainly because of high induction mortality and suboptimal management of complications. The American Society of Hematology established the International Consortium on Acute Leukemias (ICAL) to address this challenge through international clinical networking. Here, we present the findings from the International Consortium on Acute Promyelocytic Leukemia study involving 806 patients with APL recruited from 2005 to 2020 in Brazil, Chile, Paraguay, Peru, and Uruguay. The induction mortality rate has notably decreased to 14.6% compared with the pre-ICAL rate of 32%. Multivariable logistic regression analysis revealed as factors associated with induction death: age of ≥40 years, Eastern Cooperative Oncology Group performance status score of 3, high-risk status based on the Programa Español de Tratamiento en Hematologia/Gruppo Italiano Malattie EMatologiche dell'Adulto classification, albumin level of ≤3.5 g/dL, bcr3 PML/RARA isoform, the interval between presenting symptoms to diagnosis exceeding 48 hours, and the occurrence of central nervous system and pulmonary bleeding. With a median follow-up of 53 months, the estimated 4-year overall survival rate is 81%, the 4-year disease-free survival rate is 80%, and the 4-year cumulative incidence of relapse rate is 15%. These results parallel those observed in studies conducted in high-income countries, highlighting the long-term effectiveness of developing clinical networks to improve clinical care and infrastructure in LMIC.


  • Open Access

    A Novel Mutation in the INSR Gene Causes Severe Insulin Resistance and Rabson–Mendenhall Syndrome in a Paraguayan Patient

    by Maria Natalia Rojas Velazquez, Fabiola Blanco, Ana Ayala-Lugo, Lady Franco, Valerie Jolly, Denisse Di Tore, Idoia Martínez de Lapiscina, Marco Janner, Christa E. Flück, Amit V. Pandey

    Rabson–Mendenhall syndrome (RMS) is a rare autosomal recessive disorder characterized by severe insulin resistance, resulting in early-onset diabetes mellitus. We report the first case of RMS in a Paraguayan patient. The patient is a 6-year-old girl who presented with hypertrichosis, acanthosis nigricans, nephrocalcinosis, and elevated levels of glucose and insulin that served as diagnostic indicators for RMS. Genetic testing by next-generation sequencing (NGS) revealed two pathogenic variants in exons 2 and 19 of the INSR gene: c.332G>T (p.Gly111Val) and c.3485C>T (p.Ala1162Val), in combined heterozygosis. The novel INSR c. 332G>T variant leads to the substitution of glycine to valine at position 111 in the protein, and multiple in silico software programs predicted it as pathogenic. The c.3485C>T variant leads to the substitution of alanine to valine at position 1162 in the protein previously described for insulin resistance and RMS. The management of RMS is particularly challenging in children, and the use of metformin is often limited by its side effects. The patient was managed with nutritional measures due to the early age of onset. This report expands the knowledge of RMS to the Paraguayan population and adds a novel pathogenic variant to the existing literature.


  • Open Access

    A Novel Mutation in the INSR Causes Severe Insulin Resistance and Rabson-Mendenhall Syndrome in a Paraguayan Patient

    by Maria Natalia Rojas Velazquez, Fabiola Blanco, Ana Ayala-Lugo, Lady Franco, Valerie Lolly, Denisse Di Torre, Idoia Martínez De Lapiscina, Marco Janner, Christa E Flück, Amit V. Pandey

    Rabson-Mendenhall syndrome is a rare autosomal recessive disorder characterized by severe insulin resistance, resulting in early-onset diabetes mellitus. We are reporting the first case of Rabson-Mendenhall syndrome in a Paraguayan patient. The patient is a 5-year-old girl who presented with hypertrichosis, acanthosis nigricans, and nephrocalcinosis. Genetic testing by NGS revealed two pathogenic variants in exons 2 and 18 of the INSR gene; c.332G>T (p. Gly111Val) and c.3485C>T (p. Ala1162Val), in combined heterozygosis. The novel INSR c. 332G>T variant leads to the substitution of glycine to valine at position 111 in the protein, and multiple in silico software predicted it as pathogenic. The c. 3485C>T variant leads to the substitution of alanine to valine at position 1162 in the protein previously described for insulin resistance and Rabson-Mendenhall syndrome. The management of Rabson-Mendenhall syndrome is particularly challenging in children, and the use of metformin is often limited by its side effects. The patient was managed with nutritional measures due to the early age of onset. This report expands the knowledge of Rabson-Mendenhall syndrome to the Paraguayan population and adds a novel pathogenic variant to the existing literature.


  • Open Access

    The Experience of Testing for Coronavirus Disease (COVID-19) at a Single Diagnostic Center in Paraguay before the Introduction of Vaccination

    by Florencia Del-Puerto, Leticia E. Rojas, Chyntia C. Díaz Acosta, Laura X. Franco, Fátima Cardozo, María E. Galeano, Adriana Valenzuela, Alejandra Rojas, Magaly Martínez, Ana Ayala-Lugo, et al.

    Soon after the declaration of the COVID-19 pandemic, the Institute for Health Sciences Research (IICS) of the National University of Asunción, Paraguay became a testing laboratory (COVID-Lab) for SARS-CoV-2. The COVID-Lab testing performance was assessed from 1 April 2020 to 12 May 2021. The effect of the pandemic on the IICS and how the COVID-Lab contributed to the academic and research activities of the institute were also assessed. IICS researchers and staff adjusted their work schedules to support the COVID-Lab. Of the 13,082 nasopharyngeal/oropharyngeal swabs processed, 2704 (20.7%) tested positive for SARS-CoV-2 by RT-PCR. Of the individuals testing positive, 55.4% were female and 48.3% were aged 21–40 years. Challenges faced by the COVID-Lab were unstable reagent access and insufficient staff; shifting obligations regarding research, academic instruction, and grantsmanship; and the continuous demands from the public for information on COVID-19. The IICS provided essential testing and reported on the progress of the pandemic. IICS researchers gained better laboratory equipment and expertise in molecular SARS-CoV-2 testing but struggled to manage their conflicting educational and additional research obligations during the pandemic, which affected their productivity. Therefore, policies protecting the time and resources of the faculty and staff engaged in pandemic-related work or research are necessary components of healthcare emergency preparedness.


  • Association of class II HLA alleles with susceptibility to develop immune‐mediated diseases in Paraguayan patients

    by Isabel Acosta‐Colman, Sonia Cabrera‐Villalba, Ana Ayala‐Lugo, Valerie Jolly, Marcos Vazquez, Zoilo Morel, Patricia Langjahr, Margarita Duarte, Ruth Zarate, Maria Eugenia Acosta, et al.

    Genetic and nongenetic factors are involved in the pathogenesis of immune-mediated inflammatory diseases (IMIDs). The best-known genetic factor for susceptibility to IMIDs is the human leukocyte antigen (HLA). The aim of the present study was to evaluate the association of HLA class II genes with the risk of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc) in the Paraguayan population. We included 254 patients with IMIDs (101 SLE, 103 RA, and 50 SSc) and 50 healthy controls. The haplotypes of five genes corresponding to HLA class II genes and their relationship to the IMIDs studied were determined. Note that 84.6% were women, with a mean age of 43.4 +/- 14 years. Among the associated HLA alleles, we found the previously identified risk factors in other populations like HLA-DRB1*03:01 and HLA-DRB1*14:02 for RA, as well as new ones not previously identified, such as DPA1*02:01 for SLE and, DB1*02:01 for RA and SSc. In the genetic association analysis, already known associations have been replicated, and unpublished associations have been identified in Paraguayan patients with IMIDs. This is the first genetic association study in Paraguayan patients with IMIDs.


  • Open Access

    AB0015 STUDY OF VDR AND VDBP GENES AS CANDIDATE SUSCEPTIBILITY GENES FOR THE DEVELOPMENT OF IMMUNE-MEDIATED DISEASES IN THE PARAGUAYAN POPULATION

    by I. Acosta-Colman, M. Vazquez, S. Cabrera-Villalba, A. Ayala-Lugo, M. E. Acosta, I. Arevalo de Guillen, V. Jolie, M. Duarte, V. Valinotti, R. Contreras, et al.

    Background: Immune Mediated Inflammatory Diseases (IMIDs) are complex diseases that are believed to have a strong interaction between the genome and the environment as part of their aetiology. In studies using the candidate gene strategy, genetic variation in a gene where functionality has been associated with the pathophysiology of the disease under study is being analyzed. In the last decade, polymorphisms of the vitamin D receptor (VDR) and VDBP genes have been more emphatically studied in IMIDs in different populations, but the results reported have not yet been conclusive. Objectives: To identify an association between vitamin D receptor (VDR) and vitamin D-binding protein (VDBP) gene polymorphisms, and IMIDs in Paraguayan patients. Methods: Association study of VDR (SNPs rs731236, rs7975232, rs2228570) and VDBP (rs4588) gene polymorphisms with susceptibility to IMIDs in Paraguayan population. A total of 399 patients with IMIDs (i.e. Systemic Lupus Erythematosus (SLE), Scleroderma (ES), Rheumatoid Arthritis (RA), and Cutaneous Psoriasis (CPS) and 100 hypernormal controls (HC) from the same population were included in this study. Genotyping was performed using Taqman real-time PCR-based technology (Life Technologies, USA). Statistical analysis was performed using Rv3.0.1 statistical language software (www.R-project.org). A p value ≤ 0.05 was used for statistical significance. Results: A total of 399 individuals, 100 controls and 299 patients (99 RA, 100 SLE, 50 ES, and 50 PSO) were included. Seventy-six percent were female and 24% were male. The mean age was 43.7±14 years. Four SNPs were genotyped: rs731236, rs7975232, rs2228570, rs4588. The HWE test was not statistically significant for any of the 4 SNPs considered (P>0.05), confirming the quality of genotyping and the absence of technical bias. (Table 1). Genotyping of SNPs of the VDR and VDBP gene in Paraguayan population with IMIDs. Conclusion: There is evidence of nominal association between VDR SNPs: rs731236 (in SLE and CPS), and rs7975232 (in SS and CPS) and the presence of IMIDs disease in Paraguayan patients. Disclosure of Interests: None declared